Round table: Endurance Unveiled: TCR Therapies Showcasing Durability in Solid Tumors
Time: 3:00 pm
day: DAY ONE TRACK 3 B
Details:
- Discuss key clinical trials highlighting the enduring efficacy of TCR therapies in solid tumors, emphasizing long-term patient responses and sustained anti-tumor effects
- Explore the underlying mechanisms contributing to the durability of TCR therapies in solid tumors, delving into factors influencing persistence and resistance patterns
- Engage patients and experts to discuss lived experiences and future expectations regarding the long-lasting benefits of TCR therapies in managing solid tumors
